cemiplimab
regeneron,sanofi
['cemiplimab', 'nsclc', 'sclc']
cemiplimab is a new player in front-line high-pdl1 mnsclc. continuation of treatment beyond pd is probably an interesting option.
#esmo2022 
Head of pulmonology unit @pneumo_LS @CHUdeLyon
Professor of Pulmonology @UnivLyon1
Scientific head @URCOT_lyon & @IFCTlung
#liquidbiopsy~#screening~????